Pharmacokinetics of Obinutuzumab (GA101) in Patients with CD20+Relapsed/Refractory Malignant Disease Receiving Concomitant Chemotherapy (Phase Ib Study BO21000)

David Carlile; Georgina Meneses-Lorente; Elisabeth Wassner-Fritsch; Florence Hourcade-Potelleret; Michael K. Wenger; Guillaume Cartron; Umberto Vitolo; John Radford; Andrew Davies; Franck Morschhauser

Pharmacokinetics of Obinutuzumab (GA101) in Patients with CD20+Relapsed/Refractory Malignant Disease Receiving Concomitant Chemotherapy (Phase Ib Study BO21000)

David Carlile, Georgina Meneses-Lorente, Elisabeth Wassner-Fritsch, Florence Hourcade-Potelleret, Michael K. Wenger, Guillaume Cartron, Umberto Vitolo, John Radford, Andrew Davies, Franck Morschhauser

Research output: Contribution to journal › Article › peer-review

Original language	Undefined
Pages (from-to)	1582-1583
Number of pages	2
Journal	Blood
Volume	118
Issue number	21
Publication status	Published - 2011

Cite this

@article{53ecf195c18b429aabcf972b662ea838,

title = "Pharmacokinetics of Obinutuzumab (GA101) in Patients with CD20+Relapsed/Refractory Malignant Disease Receiving Concomitant Chemotherapy (Phase Ib Study BO21000)",

author = "David Carlile and Georgina Meneses-Lorente and Elisabeth Wassner-Fritsch and Florence Hourcade-Potelleret and Wenger, {Michael K.} and Guillaume Cartron and Umberto Vitolo and John Radford and Andrew Davies and Franck Morschhauser",

year = "2011",

language = "Undefined",

volume = "118",

pages = "1582--1583",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "21",

}

TY - JOUR

T1 - Pharmacokinetics of Obinutuzumab (GA101) in Patients with CD20+Relapsed/Refractory Malignant Disease Receiving Concomitant Chemotherapy (Phase Ib Study BO21000)

AU - Carlile, David

AU - Meneses-Lorente, Georgina

AU - Wassner-Fritsch, Elisabeth

AU - Hourcade-Potelleret, Florence

AU - Wenger, Michael K.

AU - Cartron, Guillaume

AU - Vitolo, Umberto

AU - Radford, John

AU - Davies, Andrew

AU - Morschhauser, Franck

PY - 2011

Y1 - 2011

UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000299597105432&KeyUID=WOS:000299597105432

M3 - Article

SN - 0006-4971

VL - 118

SP - 1582

EP - 1583

JO - Blood

JF - Blood

IS - 21

ER -

Pharmacokinetics of Obinutuzumab (GA101) in Patients with CD20+Relapsed/Refractory Malignant Disease Receiving Concomitant Chemotherapy (Phase Ib Study BO21000)

Other files and links

Cite this